332 related articles for article (PubMed ID: 19010824)
1. Luteinizing hormone-induced up-regulation of ErbB-2 is insufficient stimulant of growth and invasion in ovarian cancer cells.
Warrenfeltz SW; Lott SA; Palmer TM; Gray JC; Puett D
Mol Cancer Res; 2008 Nov; 6(11):1775-85. PubMed ID: 19010824
[TBL] [Abstract][Full Text] [Related]
2. Gonadotropin-stimulated epidermal growth factor receptor expression in human ovarian surface epithelial cells: involvement of cyclic AMP-dependent exchange protein activated by cAMP pathway.
Choi JH; Chen CL; Poon SL; Wang HS; Leung PC
Endocr Relat Cancer; 2009 Mar; 16(1):179-88. PubMed ID: 19022848
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of c-erbB-2 in hormone-dependent breast cancer cells inhibits cell growth and induces differentiation.
Giani C; Casalini P; Pupa SM; De Vecchi R; Ardini E; Colnaghi MI; Giordano A; Ménard S
Oncogene; 1998 Jul; 17(4):425-32. PubMed ID: 9696035
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase A-Ialpha subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway.
Alper O; Hacker NF; Cho-Chung YS
Oncogene; 1999 Sep; 18(35):4999-5004. PubMed ID: 10490835
[TBL] [Abstract][Full Text] [Related]
5. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
Yu D; Wolf JK; Scanlon M; Price JE; Hung MC
Cancer Res; 1993 Feb; 53(4):891-8. PubMed ID: 8094034
[TBL] [Abstract][Full Text] [Related]
6. Cyclic AMP in ovarian cancer cells both inhibits proliferation and increases c-KIT expression.
Shaw TJ; Keszthelyi EJ; Tonary AM; Cada M; Vanderhyden BC
Exp Cell Res; 2002 Feb; 273(1):95-106. PubMed ID: 11795950
[TBL] [Abstract][Full Text] [Related]
7. Reduced syndecan-1 expression stimulates heparin-binding growth factor-mediated invasion in ovarian cancer cells in a urokinase-independent mechanism.
Matsuzaki H; Kobayashi H; Yagyu T; Wakahara K; Kondo T; Kurita N; Sekino H; Inagaki K; Suzuki M; Kanayama N; Terao T
Oncol Rep; 2005 Aug; 14(2):449-57. PubMed ID: 16012729
[TBL] [Abstract][Full Text] [Related]
8. [Inhibition of invasive and chemotactic abilities of SKOV3 cells by human epithelial growth receptor-2 small interfering RNA].
Zhang SL; Lu YM; Meng LR; Zhao YY
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):48-53. PubMed ID: 17331422
[TBL] [Abstract][Full Text] [Related]
9. A novel mechanism for the modulation of luteinizing hormone receptor mRNA expression in the rat ovary.
Peegel H; Towns R; Nair A; Menon KM
Mol Cell Endocrinol; 2005 Apr; 233(1-2):65-72. PubMed ID: 15767047
[TBL] [Abstract][Full Text] [Related]
10. Decreased luteinizing hormone receptor mRNA expression in human ovarian epithelial cancer.
Lu JJ; Zheng Y; Kang X; Yuan JM; Lauchlan SC; Pike MC; Zheng W
Gynecol Oncol; 2000 Nov; 79(2):158-68. PubMed ID: 11063638
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization, localization and quantification of expression of gonadotropin receptors in Atlantic salmon (Salmo salar L.) ovaries.
Andersson E; Nijenhuis W; Male R; Swanson P; Bogerd J; Taranger GL; Schulz RW
Gen Comp Endocrinol; 2009 Sep; 163(3):329-39. PubMed ID: 19442667
[TBL] [Abstract][Full Text] [Related]
12. Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells.
Chuang TC; Hsu SC; Cheng YT; Shao WS; Wu K; Fang GS; Ou CC; Wang V
Cancer Lett; 2011 Dec; 311(1):11-9. PubMed ID: 21757288
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of c-erbB-2 expression an activity in human ovarian carcinoma cells by hypericin.
Hwang MS; Yum YN; Joo JH; Kim S; Lee KK; Gee SW; Kang HI; Kim OH
Anticancer Res; 2001; 21(4A):2649-55. PubMed ID: 11724334
[TBL] [Abstract][Full Text] [Related]
14. Paracrine regulation of growth hormone gene expression by gonadotrophin release in grass carp pituitary cells: functional implications, molecular mechanisms and signal transduction.
Zhou H; Jiang Y; Ko WK; Li W; Wong AO
J Mol Endocrinol; 2005 Apr; 34(2):415-32. PubMed ID: 15821107
[TBL] [Abstract][Full Text] [Related]
15. Luteinizing hormone inhibits Fas-induced apoptosis in ovarian surface epithelial cell lines.
Slot KA; de Boer-Brouwer M; Houweling M; Vaandrager AB; Dorrington JH; Teerds KJ
J Endocrinol; 2006 Feb; 188(2):227-39. PubMed ID: 16461549
[TBL] [Abstract][Full Text] [Related]
16. Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells.
Steller MD; Shaw TJ; Vanderhyden BC; Ethier JF
Mol Cancer Res; 2005 Jan; 3(1):50-61. PubMed ID: 15671249
[TBL] [Abstract][Full Text] [Related]
17. p38MAPK-activated AKT in HER-2 overexpressing human breast cancer cells acts as an EGF-independent survival signal.
Diehl KM; Grewal N; Ethier SP; Woods-Ignatoski KM
J Surg Res; 2007 Sep; 142(1):162-9. PubMed ID: 17612563
[TBL] [Abstract][Full Text] [Related]
18. cAMP-induced expression of the orphan nuclear receptor Nur77 in MA-10 Leydig cells involves a CaMKI pathway.
Martin LJ; Boucher N; El-Asmar B; Tremblay JJ
J Androl; 2009; 30(2):134-45. PubMed ID: 18835829
[TBL] [Abstract][Full Text] [Related]
19. Targeted eradication of ovarian cancer mediated by intracellular expression of anti-erbB-2 single-chain antibody.
Deshane J; Cabrera G; Grim JE; Siegal GP; Pike J; Alvarez RD; Curiel DT
Gynecol Oncol; 1995 Oct; 59(1):8-14. PubMed ID: 7557620
[TBL] [Abstract][Full Text] [Related]
20. [Influence of estrogen and progestin on nm23-H1 expression in epithelial ovarian cancer cell lines via activation of phosphorylation signaling].
Hua KQ; Yao LQ; Cao Q; Huang Y; Zhao YQ; Feng YJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):756-61. PubMed ID: 17327034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
